Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
COVID-19 has presented a variety of challenges. The way people live their lives and conduct their work has been disrupted....
Tags: Pharm-Olam Insights, COVID-19
Earned Value Management or EVM is changing the way that companies do business. You may have heard that statement before, about...
Tags: Pharm-Olam Insights
Risk assessments are often an afterthought. A company is required to be audited, and the auditor finds gaps or holes in its...
Tags: Pharm-Olam Insights, CRO Services
Medicine is continually advancing. New bodily mechanisms are uncovered and understood as analytical platforms improve. It...
Tags: Pharm-Olam Insights
Ventilator-Associated Pneumonia (VAP) is a common complication of mechanical ventilation. Overall, the percentage of VAP or...
Tags: COVID-19
Clinical trials continue to evolve and so do the methodologies used to support and provide the vital clinical trial monitoring...
Tags: Pharm-Olam Insights, CRO Services
Rare disease drug development varies from the pathways seen in more established indications. The sample sizes are often...
Pharm-Olam is committed to following our industry’s best practices – sometimes even those from other segments of our industry....
Tags: Data Management
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
